v3.25.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Total Stockholders’ Equity
Total Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Total Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Noncontrolling Interest
Noncontrolling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2023             25,430,566 25,430,566                  
Beginning balance at Dec. 31, 2023 $ 649,793 $ (532) $ 649,261 $ 649,704 $ (532) $ 649,172 $ 127,692 $ 127,692 $ 692,760 $ (532) $ 692,228 $ (155,195) $ (155,195) $ (15,553) $ (15,553) $ 89 $ 89
Comprehensive income:                                  
Net income 45,950     45,950         45,950                
Other comprehensive income (loss), net of tax (15,263)     (15,263)               (15,263)          
Cash dividends declared and paid (24,637)     (24,637)         (24,637)                
Treasury shares purchased under deferred directors' plan (in shares)             (4,578)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 291             (291)      
Treasury shares sold and distributed under deferred directors' plan (in shares)             13,275                    
Treasury shares sold and distributed under deferred directors' plan 0     0     $ (391)             391      
Stock activity under equity compensation plans (in shares)             64,481                    
Stock activity under equity compensation plans (2,596)     (2,596)     $ (2,596)                    
Stock based compensation expense 1,875     1,875     $ 1,875                    
Ending balance (in shares) at Jun. 30, 2024             25,503,744                    
Ending balance at Jun. 30, 2024 654,590     654,501     $ 126,871   713,541     (170,458)   (15,453)   89  
Beginning balance (in shares) at Mar. 31, 2024             25,503,425                    
Beginning balance at Mar. 31, 2024 647,009     646,920     $ 125,873   703,330     (166,913)   (15,370)   89  
Comprehensive income:                                  
Net income 22,549     22,549         22,549                
Other comprehensive income (loss), net of tax (3,545)     (3,545)               (3,545)          
Cash dividends declared and paid (12,338)     (12,338)         (12,338)                
Treasury shares purchased under deferred directors' plan (in shares)             (1,348)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 83             (83)      
Stock activity under equity compensation plans (in shares)             1,667                    
Stock activity under equity compensation plans (80)     (80)     $ (80)                    
Stock based compensation expense 995     995     $ 995                    
Ending balance (in shares) at Jun. 30, 2024             25,503,744                    
Ending balance at Jun. 30, 2024 $ 654,590     654,501     $ 126,871   713,541     (170,458)   (15,453)   89  
Beginning balance (in shares) at Dec. 31, 2024 25,509,592           25,509,592                    
Beginning balance at Dec. 31, 2024 $ 683,911     683,822     $ 129,664   736,412     (166,500)   (15,754)   89  
Comprehensive income:                                  
Net income 47,051     47,051         47,051                
Other comprehensive income (loss), net of tax 5,379     5,379               5,379          
Cash dividends declared and paid (25,724)     (25,724)         (25,724)                
Treasury shares purchased under share repurchase plan (in shares)             (30,300)                    
Treasury shares purchased under share repurchase plan (1,705)     (1,705)                   (1,705)      
Treasury shares purchased under deferred directors' plan (in shares)             (4,594)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 300             (300)      
Treasury shares sold and distributed under deferred directors' plan (in shares)             12,744                    
Treasury shares sold and distributed under deferred directors' plan 0     0     $ (375)             375      
Stock activity under equity compensation plans (in shares)             37,663                    
Stock activity under equity compensation plans (1,493)     (1,493)     $ (1,493)                    
Stock based compensation expense $ 2,568     2,568     $ 2,568                    
Ending balance (in shares) at Jun. 30, 2025 25,525,105           25,525,105                    
Ending balance at Jun. 30, 2025 $ 709,987     709,898     $ 130,664   757,739     (161,121)   (17,384)   89  
Beginning balance (in shares) at Mar. 31, 2025             25,556,904                    
Beginning balance at Mar. 31, 2025 694,509     694,420     $ 130,243   743,650     (163,879)   (15,594)   89  
Comprehensive income:                                  
Net income 26,966     26,966         26,966                
Other comprehensive income (loss), net of tax 2,758     2,758               2,758          
Cash dividends declared and paid (12,877)     (12,877)         (12,877)                
Treasury shares purchased under share repurchase plan (in shares)             (30,300)                    
Treasury shares purchased under share repurchase plan (1,705)     (1,705)                   (1,705)      
Treasury shares purchased under deferred directors' plan (in shares)             (1,499)                    
Treasury shares purchased under deferred directors' plan 0     0     $ 85             (85)      
Stock based compensation expense $ 336     336     $ 336                    
Ending balance (in shares) at Jun. 30, 2025 25,525,105           25,525,105                    
Ending balance at Jun. 30, 2025 $ 709,987     $ 709,898     $ 130,664   $ 757,739     $ (161,121)   $ (17,384)   $ 89